Literature DB >> 8590112

Two-year outcome of team-based intensive case management for patients with schizophrenia.

A Aberg-Wistedt1, T Cressell, Y Lidberg, B Liljenberg, U Osby.   

Abstract

OBJECTIVES: Two-year outcomes of patients with schizophrenic disorders who were assigned to an intensive, team-based case management program and patients who received standard psychiatric services were assessed. The case management model featured increased staff contact time with patients, rehabilitation plans based on patients' expressed needs, and patients' attendance at team meetings where their rehabilitation plan was discussed.
METHODS: Forty patients were randomly assigned to either the case management group or the control group that received standard services. Patients' use of emergency and inpatient services, their quality of life, the size of their social networks, and their relatives' burden of care were assessed at assignment to the study groups and at two-year follow-up.
RESULTS: Patients in the case management group had significantly fewer emergency visits compared with the two years before the study, and their relatives reported significantly reduced burden of care associated with relationships with psychiatric services over the two-year period. The size of patients' social networks increased for the case management group and decreased for the control group.
CONCLUSIONS: A team-based intensive case management model is an effective intervention in the rehabilitation of patients with chronic schizophrenia.

Entities:  

Mesh:

Year:  1995        PMID: 8590112     DOI: 10.1176/ps.46.12.1263

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  10 in total

1.  The role of cost-consequence analysis in healthcare decision-making.

Authors:  J A Mauskopf; J E Paul; D M Grant; A Stergachis
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

Review 2.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 3.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

4.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

Review 5.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Hanna Bergman; Mariam A Khokhar; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2017-01-06

6.  A prediction model for the incidence of civil detention for crisis patients with psychiatric illnesses; the Amsterdam study of acute psychiatry VII.

Authors:  Louk F M van der Post; Jaap Peen; Jack J M Dekker
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-07-18       Impact factor: 4.328

7.  Patients with Schizophrenia and Social Contacts.

Authors:  Slavica Arsova; Gabriela Kopacheva Barsova
Journal:  Open Access Maced J Med Sci       Date:  2016-07-21

8.  At the intersection of lay and professional social networks: how community ties shape perceptions of mental health treatment providers.

Authors:  B L Perry; E Pullen; B A Pescosolido
Journal:  Glob Ment Health (Camb)       Date:  2016-02-04

9.  The effectiveness of interventions for reducing subjective and objective social isolation among people with mental health problems: a systematic review.

Authors:  Ruimin Ma; Farhana Mann; Jingyi Wang; Brynmor Lloyd-Evans; James Terhune; Ahmed Al-Shihabi; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-11-19       Impact factor: 4.328

10.  Developing interprofessional care plans in chronic care: a scoping review.

Authors:  Jerôme Jean Jacques van Dongen; Marloes Amantia van Bokhoven; Ramon Daniëls; Trudy van der Weijden; Wencke Wilhelmina Gerarda Petronella Emonts; Anna Beurskens
Journal:  BMC Fam Pract       Date:  2016-09-21       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.